Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Trikafta, a triple combination therapy for CF in patients with specific gene mutations, reaches endpoint in Phase III clinical trial The crisis of purchasing imported consumables in bulk in 10 provinc ...

Johnson & Johnson terminates global Phase III clinical trial of Stelara for the treatment of systemic lupus erythematosus Trikafta, a triple combination therapy for CF in patients with specific gene ...

INR:9523. newcastle horse racing tips today Is the Cold Winter of Private Medical Care Coming? In-depth Analysis of ...

What does the Red Queen represent in Alice in Wonderland. INR:7123. What does the Red Queen represent in Alice in Wonderland Fingolimod blocks HIV infection and transmission in hu ...

Aero flavours list️ In 2019, more than 10,000 cases were investigated and dealt with. Past stories of drug counterfeiting that were not shown on ...

The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...

The issue with CFTR modulators is that they don’t work on every CF case. However, the company developed its competitive edge ...

Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.

Vertex Pharmaceuticals VRTX announced that the FDA has approved its next-in-class vanza triple therapy for treating people ...